Achilles Therapeutics
About:
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Website: http://achillestx.com/
Twitter/X: achillestx
Top Investors: OrbiMed, RA Capital Management, Invus, Perceptive Advisors, AlbionVC
Description:
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues.
$213M
$10M to $50M
London, England, United Kingdom
2016-05-01
info(AT)achillestx.com
Charles Swanton, Karl Peggs, Mark Lowdell, Sergio Quezada
101-250
2022-07-21
Public
© 2025 bioDAO.ai